Valuation: Becton, Dickinson and Company

Capitalization 65.89B 63.51B 59.62B 52.95B 94.27B 5,771B 105B 719B 266B 2,364B 247B 242B 10,006B P/E ratio 2025 *
32.7x
P/E ratio 2026 * 28.7x
Enterprise value 82.98B 79.98B 75.08B 66.69B 119B 7,267B 132B 905B 335B 2,977B 311B 305B 12,601B EV / Sales 2025 *
3.79x
EV / Sales 2026 * 3.37x
Free-Float
77.61%
Yield 2025 *
1.76%
Yield 2026 * 1.8%
More valuation ratios * Estimated data
Dynamic Chart
1 day-7.28%
1 week-8.56%
Current month-8.24%
1 month-1.51%
3 months-5.35%
6 months-3.52%
Current year+0.15%
More quotes
1 week
224.35
Extreme 224.345
251.99
1 month
224.35
Extreme 224.345
251.99
Current year
224.35
Extreme 224.345
251.99
1 year
218.75
Extreme 218.75
251.99
3 years
215.90
Extreme 215.9
287.32
5 years
197.75
Extreme 197.75
287.32
10 years
128.87
Extreme 128.87
287.32
More quotes
Director TitleAgeSince
Chief Executive Officer 52 2020-01-27
Director of Finance/CFO 53 2021-09-05
Chief Tech/Sci/R&D Officer - 2021-11-28
Manager TitleAgeSince
Director/Board Member 74 2002-09-23
Director/Board Member 70 2006-11-19
Director/Board Member 70 2010-07-25
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
-7.28%-8.56%-4.81%-15.49%65.89B
-2.91%-0.46%+12.47%-1.15%222B
-0.95%-1.27%+3.51%-11.59%116B
-2.82%-4.77%+4.73%+80.17%47.73B
-2.96%-10.18%+2.39%+21.78%44.17B
-0.52%+0.80%-29.30%-15.96%34.5B
-0.72%-3.62%+11.35%+36.28%27.63B
-1.39%-3.91%-17.02%-17.54%23.93B
-0.75%-5.06%-15.77%-46.10%21.53B
+2.09%+1.69%-0.21%-0.22%22.25B
Average -1.80%-1.90%-3.26%+3.02% 62.65B
Weighted average by Cap. -2.46%+0.02%+2.79%+1.91%
See all sector performances

Financials

2025 *2026 *
Net sales 21.91B 21.12B 19.83B 17.61B 31.35B 1,919B 34.87B 239B 88.51B 786B 82.1B 80.48B 3,327B 23.03B 22.19B 20.83B 18.5B 32.94B 2,017B 36.64B 251B 93.01B 826B 86.27B 84.58B 3,497B
Net income 1.9B 1.83B 1.72B 1.53B 2.72B 167B 3.03B 20.75B 7.69B 68.27B 7.13B 6.99B 289B 2.47B 2.38B 2.24B 1.99B 3.54B 217B 3.93B 26.96B 9.99B 88.73B 9.27B 9.08B 376B
Net Debt 17.09B 16.47B 15.46B 13.73B 24.45B 1,497B 27.19B 186B 69.03B 613B 64.03B 62.77B 2,595B 11.76B 11.33B 10.64B 9.45B 16.82B 1,030B 18.71B 128B 47.51B 422B 44.06B 43.2B 1,786B
More financial data * Estimated data
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (49.8%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - diagnostic materials and clinical research and development tools (25.6%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc.; - interventional medical equipment (24.6%): surgical instruments, urological care products, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Employees
74,000
Calendar
More about the company
Date Price Change Volume
25-02-06 227.21 $ -7.28% 5,810,828
25-02-05 245.06 $ +1.09% 2,061,530
25-02-04 242.42 $ -2.10% 3,037,701
25-02-03 247.61 $ +0.00% 2,575,266
25-01-31 247.60 $ -0.36% 2,158,706

Delayed Quote Nyse, February 06, 2025 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
227.21USD
Average target price
278.25USD
Spread / Average Target
+22.46%
Consensus

Quarterly revenue - Rate of surprise